| Title: |
A retrospective, multicenter study on the efficacy, durability, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) for the treatment of HIV in a real-world setting in Belgium |
| Authors: |
Nasreddine, Rakan; Florence, Eric; Yombi, Jean Cyr; Henrard, Sophie; Darcis, Gilles; Van Praet, Jens; Vandekerckhove, Linos; Allard, Sabine; Demeester, Rémy; MESSIAEN, Peter; Ausselet, Nathalie; Delforge, Marc; De Wit, Stéphane |
| Contributors: |
Nasreddine, Rakan; Florence, Eric; Yombi, Jean Cyr; Henrard, Sophie; Darcis, Gilles; Van Praet, Jens; Vandekerckhove, Linos; Allard, Sabine; Demeester, Rémy; MESSIAEN, Peter; Ausselet, Nathalie; Delforge, Marc; De Wit, Stéphane |
| Publication Year: |
2023 |
| Collection: |
Document Server@UHasselt (Universiteit Hasselt) |
| Description: |
Conclusion • Several RCTs have demonstrated BIC/FTC/TAF to be a first-line option for treatment-naïve and experienced PLWH [1-4]. • Real-world studies provide complementary information to RCTs and ensure that those results can be generalized to broader populations seen in daily practice. • The aim of this study was to describe the Belgian HIV population treated with BIC/FTC/TAF and to evaluate its efficacy, durability, and tolerability in a real-world setting. |
| Document Type: |
conference object |
| File Description: |
application/pdf |
| Language: |
English |
| Relation: |
HIV Glasgow, Glasgow, 23 – 26 October 2022; https://hdl.handle.net/1942/40673 |
| Availability: |
https://hdl.handle.net/1942/40673 |
| Rights: |
info:eu-repo/semantics/openAccess |
| Accession Number: |
edsbas.26B1D7C6 |
| Database: |
BASE |